Yui Shimizu
Overview
Explore the profile of Yui Shimizu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seki T, Shimizu Y, Ishii K, Takahama Y, Kato K, Yano T
Biomolecules
. 2021 Nov;
11(11).
PMID: 34827699
Background: The occurrence of androgen-dependent prostate cancer mainly depends on prostate cancer stem cells. To reduce the risk of androgen-dependent prostate cancer, the direct elimination of prostate cancer stem cells...
2.
Matsui H, Shimizu Y, Tachikawa H, Homma T, Mizukami T, Hashimoto T, et al.
Gan To Kagaku Ryoho
. 2019 Oct;
46(10):1565-1567.
PMID: 31631140
Neoadjuvant chemotherapy(NAC)is a promising approach for the improvement of gastric cancer treatment outcome. S-1 plus cisplatin(SP)or S-1 plus oxaliplatin (SOX)is generallythe first choice of NAC regimen. We experienced that NAC...
3.
Yonezawa H, Ogawa M, Katayama S, Shimizu Y, Omori N, Oku Y, et al.
Biochem Biophys Res Commun
. 2018 Oct;
506(1):183-188.
PMID: 30342850
The Wnt/β-catenin signaling pathway controls cell proliferation and differentiation, and therefore, when this pathway is excessively activated, it causes tumorigenesis. Our chemical suppressor screening in zebrafish embryos identified antifungal azoles...
4.
Takahashi N, Kato S, Yamaji M, Ueno M, Iwabuchi R, Shimizu Y, et al.
J Org Chem
. 2017 Aug;
82(17):8882-8896.
PMID: 28782355
Tetraalkoxyphenanthrene-fused hexadecadehydro[20]- and tetracosadehydro[30]annulenes possessing octatetrayne linkages were synthesized and their properties together with those of phenanthrene-fused octadehydro[12]- and dodecadehydro[18]annulenes have been investigated. Various spectroscopic and electrochemical measurements as well...
5.
Hamada M, Ohshima K, Asai M, Shimizu Y, Ogimoto A
Int J Cardiol
. 2016 Aug;
223:422-424.
PMID: 27544598
No abstract available.
6.
Yamamoto M, Takahashi H, Takano K, Shimizu Y, Sakurai N, Suzuki C, et al.
Ann Rheum Dis
. 2016 May;
75(8):1576-8.
PMID: 27147710
No abstract available.
7.
Yajima H, Yamamoto M, Shimizu Y, Sakurai N, Suzuki C, Naishiro Y, et al.
Ann Hematol
. 2015 Sep;
95(1):35-40.
PMID: 26377996
Both multicentric Castleman's disease (MCD) and immunoglobulin (Ig)G4-related disease (IgG4-RD) are systemic diseases, presenting with hypergammaglobulinemia and elevated serum levels of IgG4. However, with regard to histopathological findings, MCD shows...
8.
Shimizu Y, Yamamoto M, Yajima H, Suzuki C, Naishiro Y, Takahashi H, et al.
Mod Rheumatol
. 2015 Sep;
26(3):391-7.
PMID: 26375328
Objectives: In immunoglobulin (Ig) G4-related disease (IgG4-RD), the mechanism of chronic inflammation and predictive factors for drug-free remission is still unclear. To examine the issues, we focused on tuberculosis, a...
9.
Yamamoto M, Shimizu Y, Yajima H, Tabeya T, Suzuki C, Naishiro Y, et al.
Mod Rheumatol
. 2015 Jul;
26(2):310-2.
PMID: 26143649
No abstract available.
10.
Yamamoto M, Yokoyama Y, Shimizu Y, Yajima H, Sakurai N, Suzuki C, et al.
Mod Rheumatol
. 2015 Jul;
26(4):633-4.
PMID: 26140465
No abstract available.